A Multifunctional Nanoplatform against Multidrug Resistant Cancer: Merging the Best of Targeted Chemo/Gene/Photothermal Therapy. (10th October 2017)
- Record Type:
- Journal Article
- Title:
- A Multifunctional Nanoplatform against Multidrug Resistant Cancer: Merging the Best of Targeted Chemo/Gene/Photothermal Therapy. (10th October 2017)
- Main Title:
- A Multifunctional Nanoplatform against Multidrug Resistant Cancer: Merging the Best of Targeted Chemo/Gene/Photothermal Therapy
- Authors:
- Cheng, Wei
Nie, Junpeng
Gao, Nansha
Liu, Gan
Tao, Wei
Xiao, Xiaojun
Jiang, Lijuan
Liu, Zhigang
Zeng, Xiaowei
Mei, Lin - Abstract:
- Abstract: Synergistic therapy that combines chemo‐, gene‐, or photothermal means shows great potential for enhancing the therapeutic effects on cancers. Tumor‐targeted nanoparticles based on a doxorubicin (DOX)‐gated mesoporous silica nanocore (MSN) encapsulated with permeability glycoprotein (P‐gp) small interfering RNA (siRNA) and a polydopamine (PDA) outer layer for DOX loading and folic acid decoration are designed. The multifunctional nanoplatform tactfully integrates chemo‐ (DOX), gene‐ (P‐gp siRNA), and photothermal (PDA layer) substances in one system. In vitro results reveal that DOX release behaviors are both pH‐ and thermal‐responsive and the release of co‐delivered P‐gp siRNA is also pH‐dependent due to the pH‐cleavable DOX gatekeeper on MSN. In addition, due to the near‐infrared light‐responsive PDA outer layer and folic acid conjugation, the nanoparticles exhibit outstanding photothermal activity and selective cell targeting ability. Subsequently, in vitro and in vivo antitumor experiments both demonstrate the enhanced antitumor efficacy of the multifunctional nanoparticles, indicating the significance of synergistic therapy combining chemo‐, gene‐, and photothermal treatments in one system. Abstract : A novel drug and siRNA codelivery system based on polydopamine‐coated drug‐self‐gated mesoporous silica is developed. This drug delivery platform possesses three different therapeutic effects: chemo‐, gene‐, and photothermal therapy. Moreover, this nanosystemAbstract: Synergistic therapy that combines chemo‐, gene‐, or photothermal means shows great potential for enhancing the therapeutic effects on cancers. Tumor‐targeted nanoparticles based on a doxorubicin (DOX)‐gated mesoporous silica nanocore (MSN) encapsulated with permeability glycoprotein (P‐gp) small interfering RNA (siRNA) and a polydopamine (PDA) outer layer for DOX loading and folic acid decoration are designed. The multifunctional nanoplatform tactfully integrates chemo‐ (DOX), gene‐ (P‐gp siRNA), and photothermal (PDA layer) substances in one system. In vitro results reveal that DOX release behaviors are both pH‐ and thermal‐responsive and the release of co‐delivered P‐gp siRNA is also pH‐dependent due to the pH‐cleavable DOX gatekeeper on MSN. In addition, due to the near‐infrared light‐responsive PDA outer layer and folic acid conjugation, the nanoparticles exhibit outstanding photothermal activity and selective cell targeting ability. Subsequently, in vitro and in vivo antitumor experiments both demonstrate the enhanced antitumor efficacy of the multifunctional nanoparticles, indicating the significance of synergistic therapy combining chemo‐, gene‐, and photothermal treatments in one system. Abstract : A novel drug and siRNA codelivery system based on polydopamine‐coated drug‐self‐gated mesoporous silica is developed. This drug delivery platform possesses three different therapeutic effects: chemo‐, gene‐, and photothermal therapy. Moreover, this nanosystem with tumor‐targeting and pH‐responsive abilities is also endowed. The enhanced tumor therapy effect is demonstrated by both in vitro and in vivo studies. … (more)
- Is Part Of:
- Advanced functional materials. Volume 27:Number 45(2017)
- Journal:
- Advanced functional materials
- Issue:
- Volume 27:Number 45(2017)
- Issue Display:
- Volume 27, Issue 45 (2017)
- Year:
- 2017
- Volume:
- 27
- Issue:
- 45
- Issue Sort Value:
- 2017-0027-0045-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2017-10-10
- Subjects:
- cancer targeted therapy -- mesoporous silica -- multidrug resistance -- polydopamine -- synergistic therapy
Materials -- Periodicals
Chemical vapor deposition -- Periodicals
620.11 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1616-3028 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/adfm.201704135 ↗
- Languages:
- English
- ISSNs:
- 1616-301X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0696.853900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7706.xml